1. Adachi, M., Yang, Y. Y., Furuichi, Y. and Miyamoto, C. (1991) Cloning and characterization of cDNA encoding human A-type endothelin receptor.
Biochem. Biophys. Res. Commun., 180: 1265-1272.
[PMID:1719979]
2. Bacon, C. R. and Davenport, A. P. (1996) Endothelin receptors in human coronary artery and aorta.
.
Br. J. Pharmacol., 117: 986-992.
[PMID:8851522]
3. Battistini, B. and Dussault, P. (1998) Blocking of the endothelin system: the development of receptor antagonists.
Pulm. Pharmacol. Ther., 11: 97-112.
[PMID:9918740]
4. Battistini, B., Berthiaume, N., Kelland, N. F., Webb, D. J. and Kohan, D. E. (2006) Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug.
Exp Biol Med (Maywood), 231: 653-695.
[PMID:16740981]
5. Bolli, MH; Marfurt, J; Grisostomi, C; Boss, C; Binkert, C; Hess, P; Treiber, A; Thorin, E; Morrison, K; Buchmann, S; et al.. (2004) Novel benzo[1,4]diazepin-2-one derivatives as endothelin receptor antagonists.
J. Med. Chem., 47 (11): 2776-95.
[PMID:15139756]
6. Clouthier, D. E., Hosoda, K., Richardson, J. A., Williams, S. C., Yanagisawa, H., Kuwaki, T., Kumada, M., Hammer, R. E. and Yanagisawa, M. (1998) Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice.
Development, 125: 813-824.
[PMID:9449664]
7. Clozel, M., Breu, V., Gray, G. A., Kalina, B., Loffler, B. M., Burri, K., Cassal, J. M., Hirth, G., Muller, M., Neidhart, W. et al.. (1994) Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
J. Pharmacol. Exp. Ther., 270: 228-235.
[PMID:8035319]
8. Clozel, M., Ramuz, H., Clozel, J. P., Breu, V., Hess, P., Loffler, B. M., Coassolo, P. and Roux, S. (1999) Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use.
J. Pharmacol. Exp. Ther., 290: 840-846.
[PMID:10411600]
9. Cyr, C., Huebner, K., Druck, T. and Kris, R. (1991) Cloning and chromosomal localization of a human endothelin ETA receptor.
Biochem. Biophys. Res. Commun., 181: 184-190.
[PMID:1659806]
10. Dasgupta, F., Mukherjee, A. K. and Gangadhar, N. (2002) Endothelin receptor antagonists - an overview.
.
Curr. Med. Chem., 9: 549-575.
[PMID:11945124]
11. Davenport, A. P. (2002) International Union of Pharmacology. XXIX. Update on endothelin receptor
nomenclature.
.
Pharmacol. Rev., 54: 219-226.
[PMID:12037137]
12. Davenport, A. P. and Battistini, B. (2002) Classification of endothelin receptors and antagonists in clinical development.
.
Clin. Sci. (Lond.), 103: 1S-3S.
[PMID:12193042]
13. Davenport, A. P. and Maguire, J. J. (2002) Of mice and men: advances in endothelin research and first antagonist gains FDA approval.
Trends Pharmacol. Sci. , 23: 155-157.
[PMID:11931980]
14. Davenport, A. P. and Russell, F. D. (2001) Endothelin converting enzymes and endothelin receptor localisation in human tissues.
Handb. Exp. Pharmacol., 152: 209-237.
15. Davenport, A. P., Kuc, R. E., Ashby, M. J., Patt, W. C. and Doherty, A. M. (1998) Characterization of [125I]-PD164333, an ETA-selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
Br. J. Pharmacol., 123: 223-230.
[PMID:9489609]
16. Davenport, A. P., Kuc, R. E., Fitzgerald, F., Maguire, J. J., Berryman, K. and Doherty, A. M. (1994) [125I]-PD15242, a selective radioligand for human ETAreceptors.
Br. J. Pharmacol., 111: 4-6.
[PMID:8012722]
17. Davenport, A. P., O'Reilly, G. and Kuc, R. E. (1995) Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type.
Br. J. Pharmacol., 114: 1110-1116.
[PMID:7620699]
18. Davenport, AP; Maguire, JJ. (2006) Endothelin.
Handb Exp Pharmacol, (176 Pt 1): 295-329.
[PMID:16999223]
19. De Oliveira, A. M., Viswanathan, M., Capsoni, S., Heemskerk, F. M., Correa, F. M. and Saavedra, J. M. (1995) Characterization of endothelinA receptors in cerebral and peripheral arteries of the rat.
.
Peptides, 16: 139-144.
[PMID:7716066]
20. Dhein, S., Giessler, C., Wangemann, T., Silber, R. E., Zerkowski, H. R. and Brodde, O. E. (2000) Differential pattern of endothelin-1-induced inotropic effects in right atria
and left ventricles of the human heart.
.
J. Cardiovasc. Pharmacol. , 36: 564-569.
[PMID:11065215]
21. Douglas, S. A. and Ohlstein, E. H. (1997) Signal transduction mechanisms mediating the vascular actions of endothelin.
J. Vasc. Res., 34: 152-164.
[PMID:9226297]
22. Elliott, J. D., Lago, M. A., Cousins, R. D., Gao, A., Leber, J. D., Erhard, K. F., Nambi, P., Elshourbagy, N. A., Kumar, C. and Lee, J. A. net al. (1994) 1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists.
J. Med. Chem., 37: 1553-1557.
[PMID:8201588]
23. Elliott, J. D., Ohlstein, E. H., Peishoff, C. E., Ellens, H. M. and Lago, M. A. (1998) Endothelin receptor antagonists.
.
Pharm. Biotechnol., 11: 113-129.
[PMID:9760678]
24. Gardiner, S. M., Compton, A. M. and Bennett, T. (1989) Regional hemodynamic effects of endothelin-1 in conscious, unrestrained, Wistar rats.
J. Cardiovasc. Pharmacol., 13: S202-S204.
[PMID:2473311]
25. Haynes, W. G. and Webb, D. J. (1994) Contribution of endogenous generation of endothelin-1 to basal vascular tone.
Lancet, 344: 852-854.
[PMID:7916401]
26. Hosoda, K., Nakao, K., Hiroshi-Arai, , Suga, S., Ogawa, Y., Mukoyama, M., Shirakami, G., Saito, Y., Nakanishi, S. and Imura, H. (1991) Cloning and expression of human endothelin-1 receptor cDNA.
FEBS Lett., 287: 23-26.
[PMID:1652463]
27. Ihara, M., Yamanaka, R., Ohwaki, K., Ozaki, S., Fukami, T., Ishikawa, K., Towers, P. and Yano, M. (1995) [3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype.
Eur. J. Pharmacol., 274: 1-6.
[PMID:7768260]
28. Johnstrom, P., Harris, N. G., Fryer, T. D., Barret, O., Clark, J. C., Pickard, J. D. and Davenport, A. P. (2002) [18F]-Endothelin-1, a positron emission tomography (PET) radioligand for the endothelin receptor system: radiosynthesis and in vivo imaging using microPET.
Clin. Sci. (Lond.), 103: 4S-8S.
[PMID:12193043]
29. Karet, F. E., Kuc, R. E. and Davenport, A. P. (1993) Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.
Kidney Int., 44: 36-42.
[PMID:8355464]
30. Kondo, S., Morita, T. and Tashima, Y. (1994) Endothelin receptor density in human hypertrophic and non-hypertrophic prostate tissue.
.
Tohoku J. Exp. Med., 172: 381-384.
[PMID:7524189]
31. Lin, H. Y., Kaji, E. H., Winkel, G. K., Ives, H. E. and Lodish, H. F. (1991) Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor.
Proc. Natl. Acad. Sci. U.S.A., 88: 3185-3189.
[PMID:1849646]
32. MacCarthy, P. A., Grocott-Mason, R., Prendergast, B. D. and Shah, A. M. (2000) Contrasting inotropic effects of endogenous endothelin in the normal and
failing human heart: studies with an intracoronary ET(A) receptor antagonist.
.
Circulation, 101: 142-147.
[PMID:10637200]
33. Maguire, J. J. and Davenport, A. P. (1995) ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.
Br. J. Pharmacol., 115: 191-197.
[PMID:7647976]
34. Maguire, J. J., Kuc, R. E. and Davenport, A. P. (1997) Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ET(A) and ET(B) receptors.
.
J. Pharmacol. Exp. Ther., 280: 1102-1108.
[PMID:9023329]
35. Moravec, C. S., Reynolds, E. E., Stewart, R. W. and Bond, M. (1989) Endothelin is a positive inotropic agent in human and rat heart in vitro.
.
Biochem. Biophys. Res. Commun. , 159: 14-18.
[PMID:2647079]
36. Morris, CD; Rose, A; Curwen, J; Hughes, AM; Wilson, DJ; Webb, DJ. (2005) Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence.
Br. J. Cancer, 92 (12): 2148-52.
[PMID:15956965]
37. Ohlstein, E. H., Beck, G. R. Jr., Douglas, S. A., Nambi, P., Lago, M. A., Gleason, J. G., Ruffolo, R. R. Jr., Feuerstein, G. and Elliott, J. D. (1994) Nonpeptide endothelin receptor antagonists. II. Pharmacological
characterization of SB 209670.
.
J. Pharmacol. Exp. Ther., 271: 762-768.
[PMID:7965794]
38. Ohlstein, E. H., Nambi, P., Hay, D. W., Gellai, M., Brooks, D. P., Luengo, J., Xiang, J. N. and Elliott, J. D. (1998) Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high affinity nonpeptide ETAreceptor antagonist.
J. Pharmacol. Exp. Ther., 286: 650-656.
[PMID:9694916]
39. Ohlstein, E. H., Nambi, P., Lago, A., Hay, D. W., Beck, G., Fong, K. L., Eddy, E. P., Smith, P., Ellens, H. and Elliott, J. D. (1996) Nonpeptide endothelin receptor antagonists. VI: Pharmacological
characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
J. Pharmacol. Exp. Ther., 276: 609-615.
[PMID:8632328]
40. Okazaki, Y., Furuno, M., Kasukawa, T. and , . (2002) Analysis of the mouse transcriptome based on functional annotation of 60,770
full-length cDNAs.
Nature, 420: 563-573.
[PMID:12466851]
41. Opgenorth, T. J., Adler, A. L., Calzadilla, S. V., Chiou, W. J., Dayton, B. D., Dixon, D. B., Gehrke, L. J., Hernandez, L., Magnuson, S. R., Marsh, K. C., Novosad, E. I., Von Geldern, T. W., Wessale, J. L., Winn, M. and Wu-Wong, J. R. (1996) Pharmacological Characterization of A-127722, an orally active and highly potent ETA-selective receptor antagonist.
J. Pharmacol. Exp. Ther., 276: 473-481.
[PMID:8632312]
42. Panek, R. L., Major, T. C., Hingorani, G. P., Doherty, A. M., Taylor, D. G. and Rapundalo, S. T. (1992) Endothelin and structurally related analogs distinguish between endothelin
receptor subtypes.
.
Biochem. Biophys. Res. Commun., 183: 566-571.
[PMID:1312833]
43. Pierre, L. N. and Davenport, A. P. (1999) Blockade and reversal of endothelin-induced constriction in pial arteries from human brain.
.
Stroke, 30: 638-643.
[PMID:10066864]
44. Pollock, D. M. and Highsmith, R. F. (1998) Endothelin receptors and signalling mechanisms.
.
in
Springer. 1-224
[ISBN:3540559701]
45. Riechers, H; Albrecht, HP; Amberg, W; Baumann, E; Bernard, H; Böhm, HJ; Klinge, D; Kling, A; Müller, S; Raschack, M; et al.. (1996) Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists.
J. Med. Chem., 39 (11): 2123-8.
[PMID:8667356]
46. Russell, A. and Watts, S. (2000) Vascular reactivity of isolated thoracic aorta of the C57BL/6J mouse.
J. Pharmacol. Exp. Ther., 294: 598-604.
[PMID:10900237]
47. Schneider, M. P., Boesen, E. I. and Pollock, D. M. (2007) Contrasting Actions of Endothelin ET(A) and ET(B) Receptors in Cardiovascular Disease.
Annu Rev Pharmacol Toxicol, 47: 731–59.
[PMID:17002597]
48. Simonson, M. S. (2001) Cell signalling by endothelin peptides.
.
Handb. Exp. Pharm., 152: 115-140.
49. Takigawa, M., Sakurai, T., Kasuya, Y., Abe, Y., Masaki, T. and Goto, K. (1995) Molecular identification of guanine-nucleotide-binding regulatory proteins which couple to endothelin receptors.
Eur. J. Biochem., 228: 102-108.
[PMID:7882989]
50. Wu, C., Decker, E. R., Holland, G. W., Brown, P. M., Stavros, F. D., Brock, T. A. and Dixon, R. A. (2001) Nonpeptide endothelin antagonists in clinical development.
Drugs Today (Barc.), 37: 441-453.
[PMID:12750762]
51. Wu, C; Chan, MF; Stavros, F; Raju, B; Okun, I; Mong, S; Keller, KM; Brock, T; Kogan, TP; Dixon, RA. (1997) Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist.
J. Med. Chem., 40 (11): 1690-7.
[PMID:9171878]
52. Wu-Wong, J. R. and Opgenorth, T. J. (2001) The roles of endothelins in proliferation, apoptosis and angiogenesis.
Handb. Exp. Pharm., : 299-322.
[PMID:11689084]
53. Yanagisawa, H., Hammer, R. E., Richardson, J. A., Williams, S. C., Clouthier, D. E. and Yanagisawa, M. (1998) Role of Endothelin-1/Endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice.
J. Clin. Invest., 102: 22-33.
[PMID:9649553]
54. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. and Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells.
Nature, 332: 411-415.
[PMID:3352739]
55. Zhang, Y. F., Jeffery, S., Burchill, S. A., Berry, P. A., Kaski, J. C. and Carter, N. D. (1998) Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma.
Br. J. Cancer, 78: 1141-1146.
[PMID:9820169]
Annotated and expert reviewed. Please contact us if you can help with updates.
